Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
2.
J Pediatr ; 167(3): 757-61.e1, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26165442

ABSTRACT

K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.


Subject(s)
Cannabinoids/adverse effects , Designer Drugs/adverse effects , Myocardial Ischemia/chemically induced , Adolescent , Electrocardiography , Humans , Male , Tachycardia, Sinus/chemically induced , Troponin I/blood
SELECTION OF CITATIONS
SEARCH DETAIL